Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study

Grant

Date/time Interval

  • May 15, 2019 - December 31, 2020

    • Awarded By

    Total Award Amount

  • 511575.00

    • Direct Costs

  • 344495.00

    • Sponsor Award Id

  • R01AG063689

    • Contributor

  • Bryan Smelser   Investigator  
  • David Geldmacher   Investigator  
  • Erik Roberson   Investigator  
  • Marissa Natelson Love   Principal Investigator  
  • Roberta May   Investigator